Condom Market 2024 Analysis, Research, Review, Applications and Forecast to 2030
Condom Industry Overview
The global condom market size was estimated at USD 11.59 billion
in 2023 and is expected to grow at a CAGR of 8.72% from 2024 to 2030. The
increase in awareness regarding the use of condoms, measures to reduce the
spread of HIV & other Sexually Transmitted Infections (STIs), and the
availability of different types of products to suit consumer needs are likely
to drive market growth during the forecast period.
According to the World Health Organization (WHO) in 2023,
approximately 374 million new cases of syphilis, gonorrhea, chlamydia, and
trichomoniasis were reported annually. In the same year, WHO reported that 39.0
million people were living with HIV globally, with two-thirds of them residing
in the African countries. This can lead to serious complications beyond the
immediate effect of the infection itself. If left untreated, STDs can lead to
complications such as impotence and infertility. According to a study published
on Factors associated with adverse pregnancy outcomes of maternal syphilis in
Henan, China, 2016-2022, in 2016, around 1 million pregnant women were detected
with active syphilis, which resulted in 200,000 stillbirths and 350,000 adverse
birth outcomes. This is expected to boost demand for the use of condoms during
the forecast period.
Gather
more insights about the market drivers, restrains and growth of the Condom Market
The male condom segment dominated the market with a revenue share
of 98.74% in 2023. The growth can be attributed to factors such as
manufacturers' focus on the production of male condoms, open-mindedness
regarding their use as compared to female condoms, and diverse portfolios.
Underdeveloped countries in Africa have a high unmet demand for male condoms
due to the increasing prevalence of HIV/AIDS. These are mostly the preferred
option among couples, resulting in higher demand.
Moreover, male condoms have a variety of options in terms of
materials, thickness, designs, and colors, which promotes their use. They are
commonly used methods of contraception. According to the U.S. Census data and
Simmons National Consumer Survey data, around 33.44 million Americans used
condoms in 2020. This is anticipated to drive the segment growth during the
forecast period.
The female condom segment is estimated to witness the fastest CAGR
during the forecast period. These are being increasingly accepted for reducing
the risk of STIs and unplanned pregnancies. Despite female condoms being a
lifesaving product and easy availability, their distribution & use are
quite low as most of the family planning and HIV prevention programs have not
embraced female condoms. However, female condoms are gaining immense popularity
of late, especially among single women.
Browse
through Grand View Research's Medical Devices Industry Research Reports.
• The global intrauterine
devices market size was estimated at USD 6.25 billion in 2023 and is projected
to grow at a CAGR of 3.66% from 2024 to 2030.
• The global dual
chamber prefilled syringes market size was valued at USD 167.3 million
in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.
Key Condom
Company Insights
The market is highly competitive, with the presence of multiple
major players. The market is witnessing the presence of numerous country-level
players, alongside the introduction of smaller competitors poised to gain a
substantial market share. This trend is reflective of the competitive landscape
in the industry. Some emerging players in the market are, Jems and Slipp in
Canada, Bleu in India, Get Down and Jonny in Australia, and Hanx in the UK.
Key Condom
Companies:
The following are the leading companies in the condom market.
These companies collectively hold the largest market share and dictate industry
trends.
·
FUJILATEX CO.,LTD
·
Reckitt Benckiser Group PLC
·
Church & Dwight Co., Inc.
·
Karex Berhad
·
LELO iAB
·
Lifestyles
·
Veru Inc.
·
Okamoto Industries, Inc
·
MAYER LABORATORIES, INC.
·
Cupid Limited
·
RITEX GMBH
·
Pasante Healthcare Ltd.
·
CPR GmbH
·
Mankind Pharma
·
Sagami Rubber Industries Co., Ltd.
·
rrtMedcon
Recent
Developments
In April 2023, Veru Inc. has entered into a Purchasing Agreement
with Afaxys Group Services, LLC (AGS) to offer Veru’s FC2 Female Condom
(internal condom) through the AGS Group Purchasing Organization (GPO). This
agreement will benefit up to 31 million women and men who depend on community
& public health centers for essential healthcare.
In May 2021, SKYN, the leading sexual wellness brand and maker of
the nonlatex condom, has launched SKYN Excitation, a new condom with a unique
wave design featuring raised dots on the most sensitive areas. This new product
is set to enhance the sexual experience for those who use it.
Order a free sample PDF of the Condom
Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment